Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$108.85
+0.95%
Mkt Cap $20.11B
Analyst Ratings
Buy
14
Hold
5
Sell
0
Price Target (48 analysts)
$108.90
Range $84.00 – $135.00
Implied Upside
+0.0%
Consensus $108.90 vs current $108.85
NASDAQ·Healthcare·Biotechnology
$108.85
+0.95%
Mkt Cap $20.11B
Buy
14
Hold
5
Sell
0
Price Target (48 analysts)
$108.90
Range $84.00 – $135.00
+0.0%
Consensus $108.90 vs current $108.85